ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.035,20
-0,53%
S&P 500
5.107,12
-0,18%
Dow Jones
38.154,45
-0,60%
Euro vs US Dollar
1,07117
-0,04%
Bitcoin
60.781,30
-4,79%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Adma Biologics Inc (ADMA)

  7. Adma Biologics Inc (ADMA) News

ADMA

Adma Biologics (ADMA)

Adma Biologics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ADMA
DatumZeitQuelleÜberschriftSymbolFirma
11/03/202421h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
11/03/202417h19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADMAAdma Biologics Inc
11/03/202412h00GlobeNewswire Inc.ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®NASDAQ:ADMAAdma Biologics Inc
09/03/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
05/03/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
05/03/202413h00GlobeNewswire Inc.ADMA Biologics to Participate in the Raymond James Institutional Investor ConferenceNASDAQ:ADMAAdma Biologics Inc
05/03/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
29/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
29/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
29/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
29/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
29/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
29/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
28/02/202422h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
28/02/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
28/02/202422h10GlobeNewswire Inc.ADMA Biologics Announces CFO TransitionNASDAQ:ADMAAdma Biologics Inc
28/02/202422h05GlobeNewswire Inc.ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
28/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
21/02/202422h05GlobeNewswire Inc.ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:ADMAAdma Biologics Inc
21/02/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
21/02/202413h00GlobeNewswire Inc.ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlyticsNASDAQ:ADMAAdma Biologics Inc
14/02/202417h50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADMAAdma Biologics Inc
08/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
08/01/202413h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
08/01/202413h00GlobeNewswire Inc.ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
06/01/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
18/12/202322h05GlobeNewswire Inc.ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares ManagementNASDAQ:ADMAAdma Biologics Inc
12/12/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
12/12/202313h00GlobeNewswire Inc.ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and OlderNASDAQ:ADMAAdma Biologics Inc
16/11/202322h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:ADMA

Kürzlich von Ihnen besucht

FX
EURGBP
Euro vs Sterling
NASDAQ
AMZN
Amazon.com
DBI
SDXP
SDAX
TG
CBK
Commerzbank
TG
RHM
Rheinmetall
COIN
ETHUSD
Ethereum
TG
BAS
BASF
COIN
BTCUSD
Bitcoin
TG
BAYN
Bayer
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
KO
Coca Cola
FX
EURUSD
Euro vs US Dollar
CCOM
US500
US 500
AMEX
XLV
Health Care Select Sector
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten